Linnaeus Therapeutics Patents – Insights & Stats (Updated 2023)

Linnaeus Therapeutics has a total of 18 patents globally, out of which 2 have been granted. Of these 18 patents, more than 83% patents are active. The United States of America is where Linnaeus Therapeutics has filed the maximum number of patents, followed by South Africa, Canada and Australia. Parallelly, The United States of America seems to be the main focused R&D center and also the origin country of Linnaeus Therapeutics.

Linnaeus Therapeutics was founded in the year 2015. Linnaeus Therapeutics is a biotech start up. This Company creates and sells medications for treating cancer.

Do read about some of the most popular patents of Linnaeus Therapeutics which have been covered by us in this article and also you can find Linnaeus Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Linnaeus Therapeutics patent portfolio.

How many patents does Linnaeus Therapeutics have?

Linnaeus Therapeutics has a total of 18 patents globally. These patents belong to 4 unique patent families. Out of 18 patents, 15 patents are active.

How Many Patents did Linnaeus Therapeutics File Every Year?

Linnaeus Therapeutics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantLinnaeus Therapeutics Applications FiledLinnaeus Therapeutics Patents Granted
202311
20225
202141
20198

How many Linnaeus Therapeutics patents are Alive/Dead?

Worldwide Patents

Linnaeus Therapeutics Patent Portfolio

How Many Patents did Linnaeus Therapeutics File in Different Countries?

Linnaeus Therapeutics Worldwide Patent Filing

Countries in which Linnaeus Therapeutics Filed Patents

CountryPatent
United States Of America4
South Africa2
Canada2
Australia2
Brazil1
Europe1
Mexico1
New Zealand1
Israel1

Where are Research Centers of Linnaeus Therapeutics Patents Located?

R&D Centres of Linnaeus Therapeutics

What Percentage of Linnaeus Therapeutics US Patent Applications were Granted?

Linnaeus Therapeutics (Excluding its subsidiaries) has filed 2 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 1 have been granted leading to a grant rate of 50.0%.

Below are the key stats of Linnaeus Therapeutics patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Linnaeus Therapeutics?

Law FirmTotal ApplicationsSuccess Rate
Mcdonnell Boehnen Hulbert & Berghoff250.0%

List of Linnaeus Therapeutics patents

Linnaeus Therapeutics PatentsTitle
US11760749B2Enantiomerically Purified Gper Agonist For Use In Treating Disease States And Conditions
US10934277B2Enantiomerically Purified Gper Agonist For Use In Treating Disease States And Conditions
US20220089576A1Enantiomerically Purified Gper Agonist For Use In Treating Disease States And Conditions
EP3823617A4Enantiomerically Purified Gper Agonist For Use In Treating Disease States And Conditions
WO2022245899A3Diagnostic Methods And Compositions For Treatment Of Cancer
AU2022254072A1Oncologic Variations Associated With Cancer And Methods Of Treatment
CA3214822A1Oncologic Variations Associated With Cancer And Methods Of Treatment
AU2019310029A1Enantiomerically Purified Gper Agonist For Use In Treating Disease States And Conditions
CA3107109A1Enantiomerically Purified Gper Agonist For Use In Treating Disease States And Conditions
IL280283AEnantiomerically Purified Gper Agonist For Use In Treating Disease States And Conditions
BR112021001031A2Compound, Pharmaceutical Composition, Cosmetic Composition, And, Methods To Treat Or Prevent A Disease Or Disorder, To Prevent Or Reduce The Likelihood Of Pregnancy After Sexual Intercourse, To Treat Or Prevent Type 2 Diabetes, To Increase Or Prevent Or Reverse Loss For Skin Pigmentation, Skin Protection And To Treat Or Prevent Cancer, Prevent The Recurrence Of Cancer Or Stop The Progression Of Cancer
ZA202309345AOncologic Variations Associated With Cancer And Methods Of Treatment
NZ804356AOncologic Variations Associated With Cancer And Methods Of Treatment
MX2021000809AEnantiomerically Purified Gper Agonist For Use In Treating Disease States And Conditions.
ZA202100381AEnantiomerically Purified Gper Agonist For Use In Treating Disease States And Conditions
US20200024262A1Enantiomerically Purified Gper Angonist For Use In Treating Disease States And Conditions
WO2022216893A1Oncologic Variations Associated With Cancer And Methods Of Treatment
WO2020023391A1Enantiomerically Purified Gper Agonist For Use In Treating Disease States And Conditions

What are Linnaeus Therapeutics key innovation segments?

What Technologies are Covered by Linnaeus Therapeutics?

The chart below distributes patents filed by Linnaeus Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Linnaeus Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Linnaeus Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Linnaeus Therapeutics?

Related Articles

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.